23andMe Mounts PR Defense
Tue., Nov. 26, 2013
By Greg Hazley
Personal DNA testing kit marketer 23andMe is mounting a defense after the Food and Drug Administration on Nov. 22 ordered the company to stop selling its kits without marketing clearance.
Read Full Story in Subscriber Area
Category: Healthcare PR
More Healthcare PR posts from O'Dwyer's:
• | Real Chemistry’s Isidro Shifts NarrativeWed., Feb. 28, 2024 |
• | Fernandez Takes Healthcare Post in BerkshiresMon., Jan. 15, 2024 |
• | Weber Shandwick Alum Bargar Joins GCI HealthThu., Dec. 14, 2023 |
• | JPA Health to Support National SAMHSA CampaignThu., Oct. 26, 2023 |
• | The Essential Elements of Thought LeadershipMon., Oct. 23, 2023 |
No comments have been submitted for this story yet.